Dr. Victor F. Tapson, MD

Dr. Tapson practices at Cedars-Sinai Medical Center in West Hollywood, California.

Dr. Tapson's NPI, 1275693400, was assigned on December 11, 2006. Dr. Tapson graduated from Drexel University College Of Medicine in 1982. Dr. Tapson's California license number on file is G127944.

Dr. Tapson's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, West Hollywood, CA 90048 in Los Angeles County. The practice phone is (323) 866-8600.

Dr. Tapson's primary practice is Cedars-Sinai Medical Center in West Hollywood, California. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tapson practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Tapson's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Tapson is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Tapson's licenses on file in 3 states: California, North Carolina and Florida.

CMS data shows 330 Medicare services from Dr. Tapson across 7 procedure codes in 2021. Medicare paid $24,753 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Tapson's median patient age at 47, with 75% women.

In 2024, Dr. Tapson wrote 19 Medicare Part D claims. 0% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $17,554 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Tapson for performance year 2024, reported as part of a group.

Dmand AI links 69 papers to Dr. Tapson, published from 2008 to 2024. 2021 was the busiest year, with 7. The most frequent topics are COVID-19 and Hypertension, Pulmonary. Dr. Tapson has published most often in N Engl J Med. Dr. Tapson's most frequent co-authors are Vallerie Victoria McLaughlin, MD, Raymond Louis Benza, MD and Sudarshan Rajagopal, MD.

Dmand AI links Dr. Tapson to 13 clinical trials, 5 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Pulmonary Arterial Hypertension, Hypertension, Pulmonary and Pulmonary Embolism. Actelion sponsors the most, 4. Open Payments lists research payments to Dr. Tapson that name 2 trials.

CMS Open Payments shows 604 general payments to Dr. Tapson from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Janssen Pharmaceuticals, Inc paid the most, $218,881. It also lists 3 research payments totaling $5,060 from 2018 to 2021, naming 2 clinical trials.

Dmand AI lists 2 awards for Dr. Tapson, most recently CMS Stage 1 EHR in 2013.

Dr. Tapson graduated from Drexel University College Of Medicine in 1982.

Dr. Tapson is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.